A Non-interventional Multicenter Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
Phase of Trial: Phase IV
Latest Information Update: 04 Aug 2016
At a glance
- Drugs Rituximab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 01 Jul 2016 Status changed from active, no longer recruiting to completed.
- 01 Dec 2015 Planned End Date changed from 1 Dec 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.
- 01 Dec 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.